Stock Events

Stock Events

Dawnrays Pharmaceutical Hldgs 

HK$1.12
1
-HK$0.02-1.75% Friday 07:26

Statistics

Day High
1.13
Day Low
1.12
52W High
1.42
52W Low
1.08
Volume
24,000
Avg. Volume
-
Mkt Cap
1.68B
P/E Ratio
4.78
Dividend Yield
5.62%
Dividend
0.06

Upcoming

27
MAY
Dividend Ex
Increased
 
12
JUN
Dividend Payment
Increased
 
16
SEP
Dividend Ex
Estimated
 
2
OCT
Dividend Payment
Estimated
 
27
MAY 27
Dividend Ex
Estimated
 

Dividends

5.62%Dividend Yield
Oct 25
HK$0.02
Jun 25
HK$0.05
Jun 25
HK$0.03
Oct 24
HK$0.02
Jun 24
HK$0.07
10Y Growth
-1.73%
5Y Growth
-0.62%
3Y Growth
-10.54%
1Y Growth
N/A

Earnings

27MarExpected
Q2 2022
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0.13
0.47
0.8
1.13
Expected EPS
N/A
Actual EPS
N/A

Financials

53.36%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.26BRevenue
1.21BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2348.HK. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CSPC Pharmaceutical Group Limited.
1093.HK
Mkt Cap102.27B
Sino Biopharmaceutical is a major player in the Chinese pharmaceutical market, directly competing in similar therapeutic areas as Dawnrays.
Sino Biopharmaceutical
1177.HK
Mkt Cap85.6B
Sihuan Pharmaceutical focuses on the research and development of new drugs, overlapping with Dawnrays' market in cardiovascular and other areas.
3SBIO
1530.HK
Mkt Cap20.36B
3SBio Inc. specializes in biopharmaceutical products, competing in the Chinese market where Dawnrays also operates.
Shanghai Fosun Pharmaceutical (Group).
2196.HK
Mkt Cap104.44B
China Traditional Chinese Medicine Holdings Co. Limited competes in the pharmaceutical sector in China, offering products that can be alternatives to those of Dawnrays.
China Resources Pharmaceutical Group Limited
3320.HK
Mkt Cap42.41B
Shanghai Fosun Pharmaceutical Group is involved in both production and research, competing across several of the same therapeutic areas as Dawnrays.
Ping An Healthcare And Technology Company Limited
1833.HK
Mkt Cap34.91B
Asymchem Laboratories specializes in pharmaceutical R&D and manufacturing services, competing for market share in China's pharmaceutical industry.
Hansoh Pharmaceutical Group Company Limited
3692.HK
Mkt Cap90.49B
WuXi Biologics offers biopharmaceutical services, competing indirectly by providing services in a market where Dawnrays also operates.
Sihuan Pharmaceutical Group
460.HK
Mkt Cap0
SINOPHARM is a large conglomerate in the pharmaceutical distribution and manufacturing sector, competing broadly in the same market as Dawnrays.
SSY Group Limited
2005.HK
Mkt Cap12.13B
Luye Pharma Group focuses on drug development and manufacturing, competing in similar therapeutic categories as Dawnrays.

About

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Show more...
CEO
Ms. Kei Ling Li
Employees
1058
Country
Hong Kong
ISIN
KYG2687M1006

Listings

HK
HK
2348.HK

0 Comments

Share your thoughts

FAQ

What is Dawnrays Pharmaceutical Hldgs stock price today?▼
The current price of 2348.HK is HK$1.12 HKD — it has decreased by -1.75% in the past 24 hours. Watch Dawnrays Pharmaceutical Hldgs stock price performance more closely on the chart.
What is Dawnrays Pharmaceutical Hldgs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dawnrays Pharmaceutical Hldgs stocks are traded under the ticker 2348.HK.
Is Dawnrays Pharmaceutical Hldgs stock price growing?▼
2348.HK stock has risen by +0.9% compared to the previous week, the month change is a +0% rise, over the last year Dawnrays Pharmaceutical Hldgs has showed a -3.45% decrease.
What is Dawnrays Pharmaceutical Hldgs market cap?▼
Today Dawnrays Pharmaceutical Hldgs has the market capitalization of 1.68B
When is the next Dawnrays Pharmaceutical Hldgs earnings date?▼
Dawnrays Pharmaceutical Hldgs is going to release the next earnings report on August 21, 2026.
What is Dawnrays Pharmaceutical Hldgs revenue for the last year?▼
Dawnrays Pharmaceutical Hldgs revenue for the last year amounts to 2.26B HKD.
What is Dawnrays Pharmaceutical Hldgs net income for the last year?▼
2348.HK net income for the last year is 1.21B HKD.
Does Dawnrays Pharmaceutical Hldgs pay dividends?▼
Yes, 2348.HK dividends are paid semi-annual. The last dividend per share was 0.02 HKD. As of today, Dividend Yield (FWD)% is 5.62%.
How many employees does Dawnrays Pharmaceutical Hldgs have?▼
As of April 26, 2026, the company has 1,058 employees.
In which sector is Dawnrays Pharmaceutical Hldgs located?▼
Dawnrays Pharmaceutical Hldgs operates in the Health & Wellness sector.
When did Dawnrays Pharmaceutical Hldgs complete a stock split?▼
The last stock split for Dawnrays Pharmaceutical Hldgs was on August 06, 2018 with a ratio of 2:1.
Where is Dawnrays Pharmaceutical Hldgs headquartered?▼
Dawnrays Pharmaceutical Hldgs is headquartered in Wan Chai, Hong Kong.